Literature DB >> 9593164

In vitro antimicrobial effects of various combinations of penicillin and clindamycin against four strains of Streptococcus pyogenes.

D L Stevens1, K J Madaras-Kelly, D M Richards.   

Abstract

Previous studies using mouse models of Streptococcus pyogenes necrotizing fasciitis demonstrated that clindamycin had greater efficacy than penicillin. Frequently both agents are used concurrently in the treatment of severe S. pyogenes infections. This study investigated interactions between penicillin and clindamycin. E-test and broth microdilution assays suggested additivity or indifference, while timed-killing assays demonstrated concentration-dependent variable effects. Timed-kill studies utilizing clinical concentrations suggest that there is no antagonism with the combination of drugs but that the combination does not have a bactericidal advantage over either penicillin or clindamycin alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593164      PMCID: PMC105799          DOI: 10.1128/AAC.42.5.1266

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

2.  Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.

Authors:  M H LEPPER; H F DOWLING
Journal:  AMA Arch Intern Med       Date:  1951-10

3.  Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin.

Authors:  E JAWETZ; J B GUNNISON; R S SPECK; V R COLEMAN
Journal:  AMA Arch Intern Med       Date:  1951-03

Review 4.  Clindamycin.

Authors:  J L LeFrock; A Molavi; R A Prince
Journal:  Med Clin North Am       Date:  1982-01       Impact factor: 5.456

Review 5.  Killing and regrowth of bacteria in vitro: a review.

Authors:  W A Craig; S C Ebert
Journal:  Scand J Infect Dis Suppl       Date:  1990

6.  Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis.

Authors:  K S Kim; E L Kaplan
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

7.  Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan.

Authors:  S Maruyama; H Yoshioka; K Fujita; M Takimoto; Y Satake
Journal:  Am J Dis Child       Date:  1979-11

8.  The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

Authors:  D L Stevens; A E Gibbons; R Bergstrom; V Winn
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

9.  Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci.

Authors:  I Brook
Journal:  Pediatr Infect Dis       Date:  1985 Sep-Oct

10.  Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect.

Authors:  D L Stevens; S Yan; A E Bryant
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

View more
  11 in total

1.  Therapeutic Approaches to Streptococcal Toxic Shock Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

3.  Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis.

Authors:  Megumi Tanaka; Tadao Hasegawa; Akira Okamoto; Keizo Torii; Michio Ohta
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Group A Streptococcus pleuropneumonia associated with toxic shock syndrome in a 64-year-old woman.

Authors:  Philippe Imamdad; Patrick Miailhes; Alexie Bosch; Tristan Ferry
Journal:  BMJ Case Rep       Date:  2019-05-08

5.  Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence.

Authors:  Sadako Yoshizawa; Kazuhiro Tateda; Tomoo Saga; Yoshikazu Ishii; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

6.  Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release.

Authors:  Elizabeth A Coyle; Raymond Cha; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

7.  Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor.

Authors:  Arunasree M Kalle; Arshad Rizvi
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

Review 8.  [Clinical symptoms and therapy of necrotizing skin and soft tissue infections].

Authors:  P Kujath; M Hoffmann; E Schlöricke; L Unger; R Bouchard
Journal:  Chirurg       Date:  2012-11       Impact factor: 0.955

9.  AZDAST the new horizon in antimicrobial synergism detection.

Authors:  Navid Ziaei-Darounkalaei; Mehrdad Ameri; Taghi Zahraei-Salehi; Omid Ziaei-Darounkalaei; Tahereh Mohajer-Tabrizi; Lotfollah Bornaei
Journal:  MethodsX       Date:  2016-01-07

10.  Group A Streptococcal Sepsis.

Authors:  Dennis L. Stevens
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.